Atlas Trials

PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer

Clinical trial NCT00090870 · TERMINATED

Trial details

NCT number
NCT00090870
Sponsor
Medical University of South Carolina
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney Cancer
Start date
2002-04-01
Primary completion
2010-03-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.